Unique Facility is First New Maine Hospital in 25 Years
DENVER, March 6 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, announced today that its Wyndgate Technologies(R) division has signed an agreement with Mid Coast Hospital (Mid Coast) of Brunswick, Maine, to license its SafeTrace Tx(R) transfusion management software. Terms of the agreement were not disclosed.
Sue Ross, Director of Laboratory Services for Mid Coast Hospital, cited the extensive safety features throughout the system as the primary reasons for choosing SafeTrace Tx. "After a thorough search for transfusion software, we were impressed with Wyndgate software's ability to grow with our expanding department and interface with our existing Laboratory Information System." Ms. Ross continued, "Our hospital's recent unprecedented growth requires a user-friendly transfusion system that can grow with us. SafeTrace Tx is a Windows(R)-based system which will help create efficiencies in the lab. It will also help us to increase safety by accurately tracking patient and product compatibility."
SafeTrace Tx is uniquely designed to support the full scale of transfusion services from enterprise-wide centralized facilities to small, individual hospital laboratories. Advanced functionality in SafeTrace Tx, such as electronic crossmatch, automated patient special needs tracking and antigen/antibody functionality, will assist Mid Coast in matching patients for transfusions. SafeTrace Tx is intended to help raise the standard of care for patients, improve safety, reduce waste and increase efficiency for blood transfusion services.
Wm. Scott Dustin, Vice President of Sales and Marketing for Wyndgate Technologies, commented, "We are delighted that Mid Coast Hospital has chosen Wyndgate to manage the transfusion service in their new state-of-the-art facility. As a leading developer of blood management systems, Wyndgate's commitment to its customers is to continue to provide advanced blood management systems which are functionally rich, reliable, and help to enhance patient care and safety by providing dependable access to critical information."
About Mid Coast Hospital
Mid Coast Hospital, which opened on December 11, 2001, is the newest full-service community hospital in New England. A state-of-the-art hospital and medical center facility, it offers acute care, inpatient, and outpatient medical facilities to 22 neighboring communities. In the past year, Mid Coast has experienced tremendous growth in its clinical departments, which has resulted in significantly increased volume in its blood bank.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada, Africa, and the Caribbean. Wyndgate's software provides Vein-to-Vein(R) tracking from donor collection to patient transfusion through its Donor Doc(TM) interactive donor health history questionnaire, ElDorado Donor(TM) and SafeTrace(R) donor management systems, to its SafeTrace Tx(R) advanced transfusion management system. Global Med's PeopleMed(R), Inc. subsidiary provides custom software validation, consulting and compliance solutions to hospitals and blood centers. PeopleMed's in-depth knowledge of Wyndgate's products and the blood banking industry results in cost-effective validation services, which leads to more efficient software implementations and upgrades for our customers.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
|SOURCE Global Med Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved